Nalmefene hydrochloride injection and preparation method thereof

A technology of nalmefene and injection, which is applied in the field of nalmefene hydrochloride injection and its preparation, can solve problems such as safety, effectiveness risk, and inability to achieve stable effects, and achieve the effect of improving stability and ensuring safety

Active Publication Date: 2010-03-03
BEIJING SIHUAN PHARMA +1
View PDF1 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0012] Chinese patent literature CN1895251A also discloses "stable nalmefene hydrochloride injection and preparation method", its core is adding inorganic antioxidants such as sodium bisulfite, sodium sulfite, pyrosulfite, vitamin C in the prescription, and adding certain The antioxidant synergist edetate disodium ethylenediaminetetraacetate disodium of a certain amount, but the stability test result that carries out by this pr

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Nalmefene hydrochloride injection and preparation method thereof
  • Nalmefene hydrochloride injection and preparation method thereof
  • Nalmefene hydrochloride injection and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] Embodiment 1: This embodiment prepares 1000 nalmefene hydrochloride injections (specification: 1ml: 0.1mg),

[0025] Use the following ingredients:

[0026] Material name Feed amount

[0027] Nalmefene Hydrochloride 0.1108g (equivalent to Nalmefene 0.1g)

[0028] Sodium chloride 9g

[0029] tert-butylhydroxyanisole (BHA) 15mg

[0030] Add water for injection to 1000ml

[0031] Process steps: Take 15 mg of butyl hydroxyanisole (BHA) and 9 g of sodium chloride and add them to water for injection. After dissolving, adjust the pH to 3.8 with hydrochloric acid, add water for injection to 1000 ml, add 1.0 g of activated carbon, and decolorize at room temperature for 30 minutes After the decolorization is completed, filter with a 0.22 μm filter membrane, add 0.1108 g of nalmefene hydrochloride to the filtrate, stir and dissolve, filter with a 0.22 μm filter membrane, fill with nitrogen, and sterilize at 121 ° C for 20 minutes to obtain Nalmefene hydrochloride Fen injectio...

Embodiment 2

[0032] Embodiment 2: This embodiment prepares 1000 nalmefene hydrochloride injections (specification: 1ml: 0.1mg),

[0033] Use the following ingredients:

[0034] Material name Feed amount

[0035] Nalmefene Hydrochloride 0.1108g (equivalent to Nalmefene 0.1g)

[0036] Sodium chloride 9g

[0037] 2,6-di-tert-butyl-4-hydroxy-phenol (BHT) 60mg

[0038] Add water for injection to 1000ml

[0039] Process steps: Add 60mg of 2,6-di-tertiary hydroxy-p-cresol (BHT) and 9g of sodium chloride into water for injection, after dissolving, adjust the pH to 3.8 with hydrochloric acid, add water for injection to 1000ml, and add 1.0g of activated carbon , decolorize at room temperature for 30 minutes, filter with a 0.22 μm filter membrane after decolorization, add 0.1108 g of nalmefene hydrochloride to the filtrate, stir to dissolve, filter with a 0.22 μm filter membrane, fill with nitrogen, and sterilize with damp heat at 121°C for 20 minutes , to obtain nalmefene hydrochloride injectio...

Embodiment 3

[0040] Embodiment 3: This embodiment prepares 1000 nalmefene hydrochloride injections (specification: 1ml: 0.1mg), using the following ingredients:

[0041] Material name Feed amount

[0042] Nalmefene Hydrochloride 0.1108g (equivalent to Nalmefene 0.1g)

[0043] Sodium chloride 9g

[0044] Rosemary 20mg

[0045] Add water for injection to 1000ml

[0046] Process steps: Take 20mg of rosemary and 9g of sodium chloride and add them to water for injection. After dissolving, adjust the pH to 3.8 with hydrochloric acid, add water for injection to 1000ml, add 1.0g of activated carbon, and decolorize at room temperature for 30 minutes. Filter through a 0.22 μm filter, add 0.1108 g of nalmefene hydrochloride to the filtrate, stir to dissolve, filter with a 0.22 μm filter, fill with nitrogen and seal, and sterilize with damp heat at 121° C. for 20 minutes to obtain nalmefene hydrochloride injection.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a nalmefene hydrochloride injection, which is solution prepared from nalmefene hydrochloride and usable pharmaceutical excipients dissolved in injection water. The pharmaceutical excipients comprise an antioxidant and an osmotic pressure modifier. The nalmefene hydrochloride injection is characterized in that: the weight ratio of nalmefene to the antioxidant in the nalmefene hydrochloride is 1:0.1-1.0; and the antioxidant is mixed by one or more of tertiary butyl hydroxy anisole, 2,6-di-tert-butyl-4-methyl-phenol and rosemary. The injection is stable in property and ensures medication safety.

Description

technical field [0001] The invention relates to a pharmaceutical dosage form and a preparation method thereof, in particular to a nalmefene hydrochloride injection and a preparation method thereof. Background technique [0002] Nalmefene hydrochloride, synthesized in 1975, is another new pure opioid receptor antagonist synthesized after naloxone (NAL) and naltrexone (NTX). It can bind to opioid receptors μ, κ, and δ, and has the strongest binding effect on μ receptors. Nalmefene hydrochloride is a derivative of water-soluble NTX. The chemical structure of its 6-position methylene makes it show a long action time, multiple drug routes, high bioavailability, less side effects, stronger physiological activity, and easier penetration into biological Membrane and other properties have different effects on maintaining the normal functions of breathing, circulation, digestion, endocrine and nervous system. At present, it has been used in antagonism of narcotic analgesic respirator...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/08A61K31/485A61P9/04A61P25/30A61P3/04
Inventor 夏中宁舒军林恒庄太能
Owner BEIJING SIHUAN PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap